Sameer Joshi
Analyst, HC Wainwright
Replay available
ClearSign Technologies Corporation (NASDAQ: CLIR) Q1 2025 earnings conference call, held 2025-05-21. Replay captured from the company's public earnings webcast.

Analyst, HC Wainwright
Analyst, Marathon Microfunder
Chief Financial Officer, ClearSign Technologies
Chief Executive Officer, ClearSign Technologies
Good afternoon and welcome to the ClearSign Technologies first quarter 2025 conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the store key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press tar then the number one on your touchtone phone. To withdraw your question, please press tar then the number two. Please note this event is being recorded. I would now like to turn the conference over to Matthew Selizer of FirmIR Group. Please go ahead. Good afternoon and thank you, Operator. Welcome, everyone, to the ClearSight Technologies Corporation first quarter 2025 results conference call. During this conference call, the company will make forward-looking statements. Any statement that is not a statement of historical fact is a forward-looking statement. This includes remarks about the company's projections, expectations, plans, beliefs, and prospects. These statements are based on judgments and analysis as of the date of this conference call and are subject to numerous important risks and uncertainties that can cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties associated with the forward-looking statements made in this conference call include, but are not limited to, whether field testing and sales of ClearSign products will be successfully completed, whether ClearSign will be successful in expanding the market for its products, and other risks that are described in ClearSign's filings with the SEC, including those discussed under the Risk Factors section of the Annual Report on Form 10-K, the period ended December 31, 2024. Except ...